title: Microfluidics enables small-scale tissue-based drug metabolism studies with scarce human tissue.
abstract: Early information on the metabolism and toxicity properties of new drug candidates is crucial for selecting the right candidates for further development. Preclinical trials rely on cell-based in vitro tests and animal studies to characterize the in vivo behavior of drug candidates, although neither are ideal predictors of drug behavior in humans. Improving in vitro systems for preclinical studies both from a technological and biological model standpoint thus remains a major challenge. This article describes how microfluidics can be exploited to come closer to this goal in combination with precision-cut liver slices (PCLS) as an improved organomimetic system. Recently, we developed a novel microfluidic-based system incorporating a microchamber for slice perifusion to perform drug metabolism studies with mammalian PCLS under continuous flow. In the present study, the viability and metabolism of human PCLS were assessed by the measurement of the leakage of liver-specific enzymes and metabolism of four different substrates: lidocaine, 7-hydroxycoumarin, 7-ethoxycoumarin, and testosterone. All experiments were verified with well plates, an excellent benchmark for these experiments. Clearly, however, human tissue is not readily available, and it is worth considering how to perform a maximum number of informative experiments with small amounts of material. In one approach, the microfluidic system was coupled to an HPLC system to allow on-line monitoring and immediate detection of unstable metabolites, something that is generally not possible with conventional well-plate systems. This novel microfluidic system also enables the in vitro measurement of interorgan interactions by connecting microchambers containing different organ slices in series for sequential perfusion. This versatile experimental system has the potential to yield more information about the metabolic profiles of new drug candidates in human and animal tissues in an early stage of development compared with well plates alone.
authors.affiliation: Pharmacokinetics, Toxicology and Targeting Group, Department of Pharmacy, University of Groningen, Groningen, The Netherlands.
authors.forename: Paul M
authors.initials: PM
authors.lastname: van Midwoud
authors.forename: Marjolijn T
authors.initials: MT
authors.lastname: Merema
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Verpoorte
authors.forename: Geny M M
authors.initials: GM
authors.lastname: Groothuis
mesh_terms: D057205:Automation, Laboratory; D002851:Chromatography, High Pressure Liquid; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005434:Flow Cytometry; D006801:Humans; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D013194:Staining and Labeling